Hutchinson-Gilford progeria syndrome (HGPS)

What is progeria?

It is also known as Hutchinson-Gilford progeria syndrome (HGPS).It is a rare, fatal, disorder characterized by  segmental premature aging disease

What is the pattern of inheritance?

Autosomal Dominant

What causes this disorder?

LMNA gene single base mutation  results in the production of a mutant lamin A protein called progerin

Lamin A is an intermediate filament inner nuclear membrane protein found in most differentiated cells of the body.

What are the clinical features?

Children develop the appearance of accelerated aging, but both clinical and biologic overlaps with aging are segmental, or partial. 

Physical appearance changes dramatically each year that they age

What is the effect on IQ?

Normal 

Which organs are not affected by progeria?

Liver
Kidney 
GIT
Thyroid
Immune
CNS(except for stroke)

What are the ophthalmic effects?

exposure keratopathy 

What is the effect on hearing?

Low-tone conductive hearing loss is pervasive in progeria and indicative of a stiff tympanic membrane and/or deficits in the middle ear bony and ligamentous structures.

What are the CVS effects?

Approximately 80% of progeria deaths are caused by heart failure, possibly precipitated by events such as superimposed respiratory infection or surgical intervention. 

Progeria is a primary vasculopathy characterized by pervasive accelerated vascular stiffening, followed by large- and small-vessel occlusive disease from atherosclerotic plaque formation, with valvular and cardiac insufficiency in later years.

Risk of stroke 

Poor sexual development

What are the characteristic laboratory features?

Low serum leptin (>90% of cases)
Insulin resistance (60% cases)
relatively high platelet

Normal lipid panels, normal RFT,LFT

What are other senile syndromes?

Wiedemann-Rautenstrauch syndrome
Restrictive dermatopathy
Werner syndrome
Cockyane syndrome
Rothmung thompson 
Nester Guillermo progeria syndrome.


What are the treatment options ?


Growth hormone supplementation
Aspirin 

Inhibitor of posttranslational farnesylation of progerin -- Lonafarnib

Ongoing trial of Lonafarnib and everolimus

Trial of lonafarnib with provastatin (to lower cholesterol) and zoledronate(for osteoporosis) resultes in no benefits.

Comments

Popular posts from this blog

Congenital Hypertrophic Pyloric Stenosis

HYPOTHYROIDISM CLINICAL FEATURES

Febrile Seizure: Review